Back to GetFilings.com



 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D. C. 20549

 


 

FORM 10-Q

 


 

ý

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2004

 

or

 

o

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934

 

For the transition period from             to           

 

Commission File Number: 0-30235

 


 

Exelixis, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware

04-3257395

(State or other jurisdiction of
incorporation or organization)

(I.R.S. Employer Identification No.)

 

 

170 Harbor Way
P.O. Box 511
South San Francisco, CA 94083

(Address of principal executive offices, including zip code)

 

 

(650) 837-7000

(Registrant’s telephone number, including area code)

 


 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ý No o

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Yes ý No o

 

On October 25, 2004, there were 74,812,073 shares of common stock, par value $.001 per share, of Exelixis, Inc. outstanding.

 

 



 

EXELIXIS, INC.

 

QUARTERLY REPORT ON FORM 10-Q
FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2004

 

INDEX

 

Part I.

Financial Information

 

 

 

 

Item 1.

Unaudited Financial Statements

 

 

 

 

 

Condensed Consolidated Balance Sheets September 30, 2004 and December 31, 2003

 

 

 

 

 

Condensed Consolidated Statements of Operations Three and Nine Months Ended September 30, 2004 and 2003

 

 

 

 

 

Condensed Consolidated Statements of Cash Flows Nine Months Ended September 30, 2004 and 2003

 

 

 

 

 

Notes to Condensed Consolidated Financial Statements

 

 

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

 

 

 

Item 3.

Quantitative and Qualitative Disclosures about Market Risk

 

 

 

 

Item 4.

Controls and Procedures

 

 

 

 

Part II.

Other Informationn

 

 

 

 

Item 6.

Exhibits

 

 

 

 

Signatures

 

 

 

2



 

ITEM 1. FINANCIAL STATEMENTS

 

EXELIXIS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands)

 

 

 

September 30,
2004

 

December 31,
2003 (1)

 

 

 

(unaudited)

 

 

 

ASSETS

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

$

47,993

 

$

111,828

 

Short-term investments

 

82,851

 

125,264

 

Other receivables

 

5,090

 

3,846

 

Other current assets

 

6,532

 

3,156

 

Total current assets

 

142,466

 

244,094

 

 

 

 

 

 

 

Restricted cash and investments

 

16,390

 

4,838

 

Property and equipment, net

 

33,795

 

33,500

 

Goodwill

 

67,364

 

67,364

 

Other intangibles, net

 

3,690

 

4,136

 

Other assets

 

4,164

 

3,862

 

Total assets

 

$

267,869

 

$

357,794

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable

 

$

1,622

 

$

6,151

 

Other accrued expenses

 

9,085

 

8,632

 

Accrued compensation and benefits

 

6,330

 

6,139

 

Current portion of capital lease obligations

 

2,177

 

4,490

 

Current portion of notes payable and bank obligations

 

7,177

 

5,367

 

Deferred revenue

 

15,777

 

21,579

 

Total current liabilities

 

42,168

 

52,358

 

 

 

 

 

 

 

Capital lease obligations

 

297

 

1,790

 

Notes payable and bank obligations

 

17,791

 

14,437

 

Convertible promissory note and loan

 

85,000

 

85,000

 

Other long-term liabilities

 

6,838

 

2,952

 

Deferred revenue

 

35,108

 

39,775

 

Total liabilities

 

187,202

 

196,312

 

 

 

 

 

 

 

Commitments

 

 

 

 

 

 

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

Preferred stock

 

 

 

Common stock

 

73

 

71

 

Additional paid-in-capital

 

547,251

 

541,917

 

Notes receivable from stockholders

 

 

(53

)

Deferred stock compensation, net

 

 

(33

)

Accumulated other comprehensive income

 

794

 

1,708

 

Accumulated deficit

 

(467,451

)

(382,128

)

Total stockholders’ equity

 

80,667

 

161,482

 

 

 

 

 

 

 

Total liabilities and stockholders’ equity

 

$

267,869

 

$

357,794

 

 


(1) The condensed consolidated balance sheet at December 31, 2003 has been derived from the audited financial statement at that date but does not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements.

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

3



 

EXELIXIS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)

(unaudited)

 

 

 

Three Months Ended
September 30,

 

Nine Months Ended
September 30,

 

 

 

2004

 

2003

 

2004

 

2003

 

Revenues:

 

 

 

 

 

 

 

 

 

Contract

 

$

10,617

 

$

9,310

 

$

28,812

 

$

28,389

 

License

 

2,045

 

3,129

 

8,301

 

9,385

 

Total revenues

 

12,662

 

12,439

 

37,113

 

37,774